Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. 8-K Event Acquisition or sale completed · Unregistered share sale
  2. 8-K Event Material agreement · Other events
  3. 8-K Event Results of operations · Other events
  4. 8-K Event Shareholder vote results
  5. 8-K Event Regulation FD disclosure · Other events
  6. 8-K Event Results of operations · Other events
  7. DEF 14A Proxy Proxy Statement
  8. 8-K Event Executive or director change
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations · Other events
  11. 8-K Event Executive or director change
  12. 8-K Event Executive or director change
  13. 8-K Event Regulation FD disclosure · Other events
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
  16. 8-K Event Regulation FD disclosure · Other events
  17. 8-K Event Results of operations · Executive or director change
  18. 8-K Event Shareholder vote results
  19. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  20. 8-K Event Results of operations

Page 1 of 3 · 44 filings